US20030009029A1 - Catalytic titanium (IV) oxide, mediated geminal symmetric dialkylation of carboxamides - Google Patents

Catalytic titanium (IV) oxide, mediated geminal symmetric dialkylation of carboxamides Download PDF

Info

Publication number
US20030009029A1
US20030009029A1 US10/162,257 US16225702A US2003009029A1 US 20030009029 A1 US20030009029 A1 US 20030009029A1 US 16225702 A US16225702 A US 16225702A US 2003009029 A1 US2003009029 A1 US 2003009029A1
Authority
US
United States
Prior art keywords
atoms
radical
general formula
straight
chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/162,257
Inventor
Herwig Buchholz
Urs Welz-Biermann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Priority to US10/162,257 priority Critical patent/US20030009029A1/en
Publication of US20030009029A1 publication Critical patent/US20030009029A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/66Preparation of compounds containing amino groups bound to a carbon skeleton from or via metallo-organic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/0201Oxygen-containing compounds
    • B01J31/0211Oxygen-containing compounds with a metal-oxygen link
    • B01J31/0212Alkoxylates
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/0231Halogen-containing compounds
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/0272Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides containing elements other than those covered by B01J31/0201 - B01J31/0255
    • B01J31/0274Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides containing elements other than those covered by B01J31/0201 - B01J31/0255 containing silicon
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/0272Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides containing elements other than those covered by B01J31/0201 - B01J31/0255
    • B01J31/0275Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides containing elements other than those covered by B01J31/0201 - B01J31/0255 also containing elements or functional groups covered by B01J31/0201 - B01J31/0269
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/68Preparation of compounds containing amino groups bound to a carbon skeleton from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J21/00Catalysts comprising the elements, oxides, or hydroxides of magnesium, boron, aluminium, carbon, silicon, titanium, zirconium, or hafnium
    • B01J21/06Silicon, titanium, zirconium or hafnium; Oxides or hydroxides thereof
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J21/00Catalysts comprising the elements, oxides, or hydroxides of magnesium, boron, aluminium, carbon, silicon, titanium, zirconium, or hafnium
    • B01J21/06Silicon, titanium, zirconium or hafnium; Oxides or hydroxides thereof
    • B01J21/063Titanium; Oxides or hydroxides thereof
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/30Addition reactions at carbon centres, i.e. to either C-C or C-X multiple bonds
    • B01J2231/34Other additions, e.g. Monsanto-type carbonylations, addition to 1,2-C=X or 1,2-C-X triplebonds, additions to 1,4-C=C-C=X or 1,4-C=-C-X triple bonds with X, e.g. O, S, NH/N
    • B01J2231/3411,2-additions, e.g. aldol or Knoevenagel condensations
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/40Substitution reactions at carbon centres, e.g. C-C or C-X, i.e. carbon-hetero atom, cross-coupling, C-H activation or ring-opening reactions

Definitions

  • the present invention relates to a process for the symmetric disubstitution of carboxamides at the geminal carbonyl C atom using Grignard reagents in the presence of titanium dioxide, and to the compounds, prepared by this process, of the general formula (I)
  • R 1 , R 2 and R 3 independently of one another are H, A, Ar, —Si(R 6 ) 3 , —Sn(R 6 ) 3 , —SR 7 , —OR 7 , —NR 8 R 9 or R 1 and R 2 or R 1 and R 3 or R 8 and R 9 can be attached to one another and together form a cyclic ring having 3 to 8 C atoms which optionally contains, in addition to nitrogen, at least one further heteroatom selected from the group consisting of —S—, —O— and —NR 6 —,
  • R 4 is A, Ar, —Si(R 6 ) 3 , —Sn(R 6 ) 3 , —SR 7 , —OR 7 , —NR 8 R 9 , in which R 8 and R 9 are as defined above or R 8 and R 9 or two radicals R 4 can be attached to one another and together form a cyclic ring having 3 to 8 C atoms which can optionally contain, in addition to one nitrogen atom, at least one heteroatom selected from the group consisting of —S—, —O— and —NR 6 —,
  • R 6 , R 7 , R 8 and R 9 independently of one another are A or Ar,
  • A is a straight-chain or branched alkyl radical having from 1 to 10 C atoms, a straight-chain or branched alkenyl radical having 2 to 10 C atoms, or a straight-chain or branched alkynyl radical having 2-10 C atoms or a substituted or unsubstituted cycloalkyl radical having 3-8 C atoms, or a mono- or polyunsaturated cycloalkyl radical having 3-8 C atoms, and
  • Ar is a substituted or unsubstituted aryl radical having 6-20 C atoms.
  • R 1 , R 2 and R 3 independently of one another are H, A, Ar, —Si(R 6 ) 3 , —Sn(R 6 ) 3 , —SR 7 , —OR 7 , —NR 8 R 9 or R 1 and R 2 or R 1 and R 3 or R 8 and R 9 can be attached to one another and together form a cyclic ring having 3 to 8 C atoms which optionally contains, in addition to nitrogen, at least one further heteroatom selected from the group consisting of —S—, —O— and —NR 6 —,
  • R 4 is A, Ar, —Si(R 6 ) 3 , —Sn(R 6 ) 3 , —SR 7 , —OR 7 , —NR 8 R 9 , in which R 8 and R 9 are as defined above or R 8 and R 9 or two radicals R 4 can be attached to one another and together form a cyclic ring having 3 to 8 C atoms which can optionally contain, in addition to one nitrogen atom, at least one heteroatom selected from the group consisting of —S—, —O— and —NR 6 —,
  • R 6 , R 7 , R 8 and R 9 independently of one another are A or Ar,
  • A is a straight-chain or branched alkyl radical having from 1 to 10 C atoms, a straight-chain or branched alkenyl radical having 2 to 10 C atoms, or a straight-chain or branched alkynyl radical having 2-10 C atoms or a substituted or unsubstituted cycloalkyl radical having 3-8 C atoms, or a mono- or polyunsaturated cycloalkyl radical having 3-8 C atoms, and
  • Ar is a substituted or unsubstituted aryl radical having 6-20 C atoms
  • R 1 , R 2 and R 3 have the meanings given above for formula (I), by reaction with a nucleophilic reagent of the general formula (IIIa) or a nucleophilic reagent of the general formula (IIIb)
  • R 4 has the meaning given for the formula (I), and
  • Z is Li or MgX
  • Hal is Cl, Br or I
  • the process is carried out in the presence of catalytic amounts of a metal oxide selected from the group consisting of titanium dioxide, zirconium dioxide and hafnium dioxide.
  • the present invention also provides a corresponding process which is carried out in the presence of a cocatalyst. Accordingly, the present invention includes a process which is carried out using metal isopropoxides and alkylsilyl halides as cocatalysts; i.e. metal isopropoxides of the general formula (IV) and alkylsilyl halides of the general formula (V)
  • M′ is Al, Ca, Na, K, Si or Mg, preferably Mg or Na,
  • s is an integer from 1 to 4 and is the oxidation state of the metal
  • R is alkyl having 1 to 10 C atoms or aryl having 6 to 20 C atoms
  • X is F, Cl, Br, CN,
  • n 1 to 10
  • o 0, 2, 3,
  • the invention also provides a process, which is characterized in that
  • a carboxamide of the general formula (II), 1-15 mol %, based on the carboxamide, of a metal dioxide selected from the group consisting of titanium dioxide, zirconium dioxide and hafnium dioxide and, if appropriate, a cocatalyst are initially charged at room temperature under an atmosphere of inert gas in a solvent selected from the group consisting of toluene, THF, n-hexane, benzene and diethyl ether,
  • a′) magnesium turnings, a carboxamide of the general formula (II), 1-15 mol %, based on the carboxamide, of a metal oxide selected from the group consisting of titanium dioxide, zirconium dioxide and hafnium dioxide are initially charged at room temperature under an atmosphere of inert gas in a solvent selected from the group consisting of toluene, THF, n-hexane, benzene and diethyl ether,
  • aryl having 6 to 20 C atoms which is either unsubstituted or mono- or polysubstituted, such as phenyl, naphthyl, anthryl, phenanthryl, mono- or polysubstituted by substituents selected from the group consisting of NO 2 , F, Cl, Br, NH 2 , NHA, NA 2 , OH and OA, where A can have the meanings given above, can be mono-, poly-, or fully halogenated, preferably fluorinated, or
  • aralkenyl or aralkynyl where the aryl, alkenyl and alkynyl groups can in each case have the given meanings, such as, for example, in phenylethynyl.
  • R 1 and R 2 or R 1 and R 3 together form a cyclic ring having 3-8 C atoms which, in addition to nitrogen, contains further heteroatoms, such as —S—, —O— or —NR 6 —.
  • Particular preference is given here to compounds in which R 1 and R 2 or R 1 and R 3 form a simple cyclic ring which includes the nitrogen of the carboxamide or in which R 1 and R 2 or R 1 and R 3 form a cyclic ring which contains, as further heteroatom, an oxygen atom.
  • the nucleophilic reagent used can be a Grignard reagent or an organolithium compound of the general formulae (IIIa) or (IIIb), in which the radical
  • R 4 is preferably an alkyl radical having 1 to 10 C atoms, such as methyl, ethyl, n- or isopropyl, n-, sec- or t-butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl and suitable isomers thereof, or cycloalkyl having 3-8 C atoms, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl or corresponding methyl- or or ethyl-substituted cycloalkyl groups or mono- or polyunsaturated cycloalkyl groups, such as cyclopentenyl or cyclopentadienyl, or branched or unbranched alkenyl having 2 to 10 C atoms, such as allyl, vinyl, isopropenyl having 1
  • [0062] is an aryl radical having 6 to 20 C atoms which is either unsubstituted or mono- or polysubstituted, such as phenyl, napthyl, anthryl, phenanthryl, mono- or polysubstituted by substituents selected from the group consisting of NO 2 , F, Cl, Br, NH 2 , NHA, NA 2 , OH and OA, where A can have the meanings given above, can be mono-, poly- or fully halogenated, preferably fluorinated, or
  • [0063] is an aralkyl radical having 7 to 20 C atoms, such as benzyl, optionally mono- or polysubstituted by substituents selected from the group consisting of NO 2 , F, Cl, Br, NH 2 , NHA, NA 2 , OH and OA, where A can have the meanings given above, can be mono-, poly- or fully halogenated, preferably fluorinated,
  • [0064] is an aralkenyl or aralkynyl radical, where the aryl, alkenyl and alkynyl group can in each case have the given meanings, such as, for example, in phenylethynyl.
  • radicals R 4 in the general formula (IIIa) or (IIIb) can be —Si(R 6 ) 3 , —Sn(R 6 ) 3 , —SR 7 , —OR 7 , —NR 8 R 9 , in which R 6 , R 7 , R 8 and R 9 independently of one another can have the abovementioned meanings or R 8 and R 9 are attached to one another and together form a cyclic ring having 3 to 8 C atoms which may optionally, in addition to a nitrogen atom, contain at least one heteroatom selected from the group consisting of —S—, —O— and —NR 6 —; or
  • two radicals R 4 in the general formula (IIIb) can be an alkyl having 2-7 C atoms, so that, in the reaction according to the invention, a compound of the general formula (I) is formed in which two radicals R 4 form a cyclic ring having 3 to 8 atoms.
  • R 4 has the meaning of an alkyl radical, such as, for example, methyl, ethyl, n- or isopropyl, n-, sec- or t-butyl, pentyl, hexyl, or of a cycloalkyl radical, such as, for example, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, or of an aryl radical, such as, for example, phenyl, or of an aralkyl radical, such as, for example, benzyl.
  • an alkyl radical such as, for example, methyl, ethyl, n- or isopropyl, n-, sec- or t-butyl, pentyl, hexyl, or of a cycloalkyl radical, such as, for example, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, or
  • the radical Z in the general formulae (IIIa) and (IIIb) preferably represents a radical MgX where X is Cl or Br, or the radical Z is lithium.
  • Grignard compounds such as: methylmagnesium bromide, ethylmagnesium bromide, n- or isopropylmagnesium bromide, iso-, sec- or tert-butylmagnesium bromide, n-hexylmagnesium bromide, cyclohexylmagnesium chloride, allylmagnesium bromide, vinylmagnesium bromide, cyclopentylmagnesium bromide, cyclopentylmagnesium chloride, phenylmagnesium bromide, benzylmagnesium chloride, for the reaction.
  • Grignard compounds such as: methylmagnesium bromide, ethylmagnesium bromide, n- or isopropylmagnesium bromide, iso-, sec- or tert-butylmagnesium bromide, n-hexylmagnesium bromide, cyclohexylmagnesium chloride,
  • Suitable cocatalysts for this reaction are metal isopropoxides and alkylsilyl halides. Particularly suitable are metal isopropoxides of the general formula (IV) and alkylsilyl halides of the general formula (V)
  • M′ is Al, Ca, Na, K, Si or Mg, preferably Mg or Na,
  • s is an integer from 1 to 4 and is the oxidation state of the metal
  • R is alkyl having 1 to 10 C atoms or aryl having 6 to 20 C atoms
  • X is F, Cl, Br, CN,
  • n 1 to 10
  • o 0, 2, 3,
  • metal isopropoxides in which s is an integer from 1 to 4 and is the oxidation state of the metal and M′ is Al, Ca, Na, K, Si or Mg. Particular preference is given to Mg or Na.
  • Particularly suitable cocatalysts are, inter alia, the following silicon compounds:
  • the catalyst used can be a commercial metal dioxide selected from the group consisting of titanium dioxide, zirconium dioxide and hafnium dioxide. Preference is given to using pulverulent titanium(IV) dioxide. In the simplest case, this can be of technical grade. To ensure simple removal after the reaction has ended, it is advantageous to choose a quality which is not too fine.
  • the metal dioxide, preferably titanium dioxide, which is pre-dried by heating, is employed as a suspension in a suitable pre-dried solvent. Suitable solvents are, for example aliphatic or aromatic hydrocarbons or ethers.
  • solvents selected from the group consisting of toluene, THF, n-hexane, benzene and diethyl ether, which are dried prior to the reaction by methods known to the person skilled in the art. Drying can be carried out with the aid of magnesium sulphate, calcium chloride, sodium, potassium hydroxide or by other methods.
  • a preferred embodiment of the process according to the invention comprises initially charging the titanium dioxide used as catalyst in an amount of from 1 to 15, preferably 1.5 to 14, in particular 2 to 10 and very particularly preferably from 3 to 6 mol %, based on one mol of the amide used as starting material, in the form of a suspension adjusted to a temperature of from 10 to 30° C., preferably 15-25° C., particularly preferably to a temperature of about 20° C.
  • the starting material either as such in liquid form or dissolved in a solvent selected from the group consisting of toluene, THF, n-hexane, benzene and diethyl ether, is slowly added dropwise with stirring.
  • nucleophilic reagent prepared by methods generally known to the person skilled in the art should take place at such a rate that the temperature of the reaction mixture does not exceed 50° C. It is advantageous to carry out the addition of the nucleophilic reagent, i.e. of the Grignard reagent or the lithium compound, with efficient mixing, preferably vigorous stirring.
  • the nucleophilic reagent used preferably a Grignard reagent, is added in an amount of from 2.1 to 3 mol per mole of starting material that participates in the reaction.
  • Grignard reagent Preference is given to adding the Grignard reagent in an amount of from 2.2 to 2.6 mol, based on 1 mol of starting material. If a nucleophilic reagent or Grignard reagent of the general formula (IIIb) is used, only equimolar amounts, based on the starting material, are added to the reaction solution, corresponding to twice the number of reactive groups.
  • Another variant of the process according to the invention comprises preparing the Grignard reagent in situ by reacting magnesium with a compound of the general formula (IIIa′) or (IIIb′) in which R 4 and X have the meanings given above.
  • the amount of magnesium is preferably 2 to 5 times the molar amount, preferably 2.8 to 3.2 times the molar amount, based on the compounds of the general formula (II) used as starting material, and the amount of the compound of the general formula (IIIa′) or (IIIb′) is 2 to 3.8 times the molar amount, preferably 2.2 to 2.6 times the molar amount, based on the compound of the general formula (II).
  • the present invention also provides the use of a catalyst system comprising a metal dioxide selected from the group consisting of titanium dioxide, zirconium dioxide and hafnium dioxide as catalyst and a compound of the general formulae (IV), (V) or (VI) with the meanings given above, and the use of this catalyst system for preparing the symmetrically substituted compounds of the general formula (I).
  • reaction mixture can be carried out in a manner known to the person skilled in the art.
  • the products can be precipitated as salts using solutions of hydrochloric acid, for example a 1 molar ethereal solution of hydrochloric acid, and be filtered off and, if required, purified by recrystallization.
  • solutions of hydrochloric acid for example a 1 molar ethereal solution of hydrochloric acid
  • the products can be purified by various routes using methods known to the person skilled in the art, such as, for example, in the following manner:
  • the organic phase is extracted repeatedly with a 0.5 M acid solution, preferably an aqueous hydrochloric acid solution.
  • the extract obtained is adjusted to pH>10 using bases, preferably 2 M aqueous sodium hydroxide solution, and extracted at least once, preferably repeatedly, with diethyl ether.
  • the resulting organic phases, which contain the reaction product can be dried, if appropriate, over potassium carbonate, magnesium sulphate or sodium sulphate and be freed from the organic solvent under reduced pressure.
  • the Grignard reagents can also be replaced by the corresponding lithium compounds.
  • the corresponding lithium compounds like the Grignard reagents, can be prepared by methods generally known to the person skilled in the art, and they can be reacted according to the invention in the same manner as described above.
  • the compounds of the general formula (I) prepared according to the invention can be used, for example, as intermediates in the preparation of sulphur- or selenium-containing amines for the chiral catalysis of diethyl zinc syntheses (literature: Werth, Thomas; Tetrahydron Lett. 36; 1995, 7849-7852, Werth, Thomas et al. Helv. Chim. Acta 79, 1996, 1957-1966).

Abstract

The present invention relates to a process preparing compounds of the general formula (I)
Figure US20030009029A1-20030109-C00001
wherein R1, R2, R3 and R4 are defined herein.

Description

  • The present invention relates to a process for the symmetric disubstitution of carboxamides at the geminal carbonyl C atom using Grignard reagents in the presence of titanium dioxide, and to the compounds, prepared by this process, of the general formula (I) [0001]
    Figure US20030009029A1-20030109-C00002
  • in which [0002]
  • R[0003] 1, R2 and R3 independently of one another are H, A, Ar, —Si(R6)3, —Sn(R6)3, —SR7, —OR7, —NR8R9 or R1 and R2 or R1 and R3 or R8 and R9 can be attached to one another and together form a cyclic ring having 3 to 8 C atoms which optionally contains, in addition to nitrogen, at least one further heteroatom selected from the group consisting of —S—, —O— and —NR6—,
  • R[0004] 4 is A, Ar, —Si(R6)3, —Sn(R6)3, —SR7, —OR7, —NR8R9, in which R8 and R9 are as defined above or R8 and R9 or two radicals R4 can be attached to one another and together form a cyclic ring having 3 to 8 C atoms which can optionally contain, in addition to one nitrogen atom, at least one heteroatom selected from the group consisting of —S—, —O— and —NR6—,
  • R[0005] 6, R7, R8 and R9 independently of one another are A or Ar,
  • A is a straight-chain or branched alkyl radical having from 1 to 10 C atoms, a straight-chain or branched alkenyl radical having 2 to 10 C atoms, or a straight-chain or branched alkynyl radical having 2-10 C atoms or a substituted or unsubstituted cycloalkyl radical having 3-8 C atoms, or a mono- or polyunsaturated cycloalkyl radical having 3-8 C atoms, and [0006]
  • Ar is a substituted or unsubstituted aryl radical having 6-20 C atoms. [0007]
  • In addition to monoalkylation, geminal dialkylations using various titanium reagents have been included in studies on titanium-mediated alkylation of carbonyl functions. The geminal dimethyl structure, which is frequently found as a component in terpenes and steroids, is particularly interesting here. It has been found that a large number of ketones can be methylated with the aid of (CH[0008] 3)2TiCl2 (M. T. Reetz, J. Westermann, R. Steinbach, J. Chem. Soc., Chem. Commun. (1981) 237; M. T. Reetz, J. Westerman, S. H. Kyung, Chem. Ber. (1985) 118, 1050). However, hitherto, no studies on the transfer of other alkyl building blocks with the aid of various titanium reagents are known.
  • Geminal symmetric dialkylations of amides have been known for a long time, on account of their reactions with Grignard reagents (F. Kuffner, S. Sattler-Dornbach, W. Seifried, Mh. Chem. (1962) 93, 469). [0009]
  • Hitherto, geminal dimethylations giving high yields have only been reported for pure ketones or aldehydes, the reactions being titanium-mediated alkylations. To this end, the reagents ZnMe[0010] 2 or AlMe3 are required for synthesising the required organotitanium compound TiMe2Cl2, since ethereal solutions of MeMgCl/TiCl4 only result in a simple addition of the methyl group to keto groups (M. T. Reetz, J. Westermann, R. Steinbach, J. Chem. Soc., Chem. Commun. (1981) 237; M. T. Reetz, J. Westerman, S. H. Kyung, Chem. Ber. (1985) 118, 1050).
  • In the hitherto known symmetric dialkylations of amides which are carried out with the aid of a Grignard reagent, the products are in most cases only obtained as byproducts. The yields that are obtained are in the range of a few percent, up to at most about 50%. [0011]
    TABLE 1
    Amide Grignard Yield Lit.
    Figure US20030009029A1-20030109-C00003
    Figure US20030009029A1-20030109-C00004
    11% M. Busch, M. Fleischmann, Chem. Ber. (1910), 43, 2553
    Figure US20030009029A1-20030109-C00005
    Figure US20030009029A1-20030109-C00006
    53% R. Lukes, J. Langthaler, Collect Czech. Chem. Commun. (1959), 24, 110
    Figure US20030009029A1-20030109-C00007
    Figure US20030009029A1-20030109-C00008
    30% R. Lukes, J. Langthaler, Collect Czech. Chem. Commun. (1959), 24, 110
    Figure US20030009029A1-20030109-C00009
    Figure US20030009029A1-20030109-C00010
    41% R. Lukes, K. Smolek, Collect Czech. Chem. Commun. (1939), 11, 506
  • Accordingly, it is the object of the present invention to provide an inexpensive process which is easy to carry out and gives, from amides of the general formula (II) [0012]
    Figure US20030009029A1-20030109-C00011
  • in which R[0013] 1, R2 and R3 have the meanings given above, compounds of the general formula (I) given above which are substituted symmetrically at the geminal carbonyl C atom, in high yield.
  • This object is achieved by a process for preparing compounds of the general formula (I) [0014]
    Figure US20030009029A1-20030109-C00012
  • in which [0015]
  • R[0016] 1, R2 and R3 independently of one another are H, A, Ar, —Si(R6)3, —Sn(R6)3, —SR7, —OR7, —NR8R9 or R1 and R2 or R1 and R3 or R8 and R9 can be attached to one another and together form a cyclic ring having 3 to 8 C atoms which optionally contains, in addition to nitrogen, at least one further heteroatom selected from the group consisting of —S—, —O— and —NR6—,
  • R[0017] 4 is A, Ar, —Si(R6)3, —Sn(R6)3, —SR7, —OR7, —NR8R9, in which R8 and R9 are as defined above or R8 and R9 or two radicals R4 can be attached to one another and together form a cyclic ring having 3 to 8 C atoms which can optionally contain, in addition to one nitrogen atom, at least one heteroatom selected from the group consisting of —S—, —O— and —NR6—,
  • R[0018] 6, R7, R8 and R9 independently of one another are A or Ar,
  • A is a straight-chain or branched alkyl radical having from 1 to 10 C atoms, a straight-chain or branched alkenyl radical having 2 to 10 C atoms, or a straight-chain or branched alkynyl radical having 2-10 C atoms or a substituted or unsubstituted cycloalkyl radical having 3-8 C atoms, or a mono- or polyunsaturated cycloalkyl radical having 3-8 C atoms, and [0019]
  • Ar is a substituted or unsubstituted aryl radical having 6-20 C atoms, [0020]
  • from compounds of the formula (II) [0021]
    Figure US20030009029A1-20030109-C00013
  • in which R[0022] 1, R2 and R3 have the meanings given above for formula (I), by reaction with a nucleophilic reagent of the general formula (IIIa) or a nucleophilic reagent of the general formula (IIIb)
  • Z-R4  (IIIa)
  • Z-R4-R4-Z  (IIIb)
  • in which [0023]
  • R[0024] 4 has the meaning given for the formula (I), and
  • Z is Li or MgX where [0025]
  • X is Hal and [0026]
  • Hal is Cl, Br or I, [0027]
  • where the latter is generated in situ or added directly. [0028]
  • According to the invention, the process is carried out in the presence of catalytic amounts of a metal oxide selected from the group consisting of titanium dioxide, zirconium dioxide and hafnium dioxide. [0029]
  • The present invention also provides a corresponding process which is carried out in the presence of a cocatalyst. Accordingly, the present invention includes a process which is carried out using metal isopropoxides and alkylsilyl halides as cocatalysts; i.e. metal isopropoxides of the general formula (IV) and alkylsilyl halides of the general formula (V)[0030]
  • M′(s+)(O-isopropyl)s  (IV)
  • R3SiX  (V)
  • or of the general formula (VI)[0031]
  • R0—(X)m—Si—Y—(Si)p—(X)q—R0  (VI)
  • in which [0032]
  • M′ is Al, Ca, Na, K, Si or Mg, preferably Mg or Na, [0033]
  • s is an integer from 1 to 4 and is the oxidation state of the metal, [0034]
  • R is alkyl having 1 to 10 C atoms or aryl having 6 to 20 C atoms, [0035]
  • X is F, Cl, Br, CN, [0036]
  • m is 0, 1, [0037]
  • n is 1 to 10, [0038]
  • o is 0, 2, 3, [0039]
  • p is 0, 1 and [0040]
  • q is 0, 1, [0041]
  • with the proviso that o=3 and Y≠(CH[0042] 2)n if m=0.
  • Thus, the invention also provides a process, which is characterized in that [0043]
  • a) a carboxamide of the general formula (II), 1-15 mol %, based on the carboxamide, of a metal dioxide selected from the group consisting of titanium dioxide, zirconium dioxide and hafnium dioxide and, if appropriate, a cocatalyst are initially charged at room temperature under an atmosphere of inert gas in a solvent selected from the group consisting of toluene, THF, n-hexane, benzene and diethyl ether, [0044]
  • b) a solution comprising a nucleophilic reagent of the general formula (IIIa) or (IIIb) is added dropwise and [0045]
  • c) the mixture is allowed to react with stirring and, after the reaction has ended, worked up in a customary manner, [0046]
  • or in that, if Z=MgX, [0047]
  • a′) magnesium turnings, a carboxamide of the general formula (II), 1-15 mol %, based on the carboxamide, of a metal oxide selected from the group consisting of titanium dioxide, zirconium dioxide and hafnium dioxide are initially charged at room temperature under an atmosphere of inert gas in a solvent selected from the group consisting of toluene, THF, n-hexane, benzene and diethyl ether, [0048]
  • b′) an alkyl halide, dissolved in a solvent selected from the group consisting of toluene, THF, n-hexane, benzene and diethyl ether, and of the general formula (IIIa′) or (IIIb′)[0049]
  • X—R4  (IIIa′)
  • or
  • X—R4—R4—X  (IIIb′)
  • in which R[0050] 4 and X have the meanings given for the formula (I), is added dropwise,
  • c′) the mixture is allowed to react with stirring and, after the reaction has ended, worked up in a customary manner. [0051]
  • Experiments have shown that, using a nucleophilic reagent of the general formula (IIIa) or (IIIb), which may be a Grignard reagent and which may either be generated in situ or added as such to the reaction mixture, it is possible to convert carboxamides of the general formula (II) in the presence of catalytic amounts of titanium dioxide, zirconium dioxide or hafnium dioxide in a simple manner into symmetrically substituted compounds of the general formula (I). [0052]
  • According to the invention, using the process described herein, it is possible to convert, with good yields, carboxamides of the general formula (II) in which R[0053] 1, R2 and R3 independently of one another can have the following meanings:
  • H or [0054]
  • A i.e. branched or unbranched alkyl having 1-10 C atoms, such as methyl, ethyl, n- or isopropyl, n-, sec- or t-butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl and suitable isomers thereof, or cycloalkyl having 3-8 C atoms, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, and corresponding methyl- or ethyl-substituted cycloalkyl groups, or mono- or polyunsaturated cycloalkyl groups, such as cyclopentenyl or cyclopentadienyl, or branched or unbranched alkenyl having 2 to 10 C atoms, such as allyl, vinyl, isopropenyl, propenyl, or branched or unbranched alkynyl having 2 to 10 C atoms, such as ethynyl, propynyl, or [0055]
  • aryl having 6 to 20 C atoms which is either unsubstituted or mono- or polysubstituted, such as phenyl, naphthyl, anthryl, phenanthryl, mono- or polysubstituted by substituents selected from the group consisting of NO[0056] 2, F, Cl, Br, NH2, NHA, NA2, OH and OA, where A can have the meanings given above, can be mono-, poly-, or fully halogenated, preferably fluorinated, or
  • aralkenyl or aralkynyl, where the aryl, alkenyl and alkynyl groups can in each case have the given meanings, such as, for example, in phenylethynyl. [0057]
  • Good yields are in particular also obtained using carboxamides in which R[0058] 1 and R2 or R1 and R3 together form a cyclic ring having 3-8 C atoms which, in addition to nitrogen, contains further heteroatoms, such as —S—, —O— or —NR6—. Particular preference is given here to compounds in which R1 and R2 or R1 and R3 form a simple cyclic ring which includes the nitrogen of the carboxamide or in which R1 and R2 or R1 and R3 form a cyclic ring which contains, as further heteroatom, an oxygen atom.
  • Thus, high yields are obtained in this manner when the starting materials used are compounds such as, for example, [0059]
    Figure US20030009029A1-20030109-C00014
  • The nucleophilic reagent used can be a Grignard reagent or an organolithium compound of the general formulae (IIIa) or (IIIb), in which the radical [0060]
  • R[0061] 4 is preferably an alkyl radical having 1 to 10 C atoms, such as methyl, ethyl, n- or isopropyl, n-, sec- or t-butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl and suitable isomers thereof, or cycloalkyl having 3-8 C atoms, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl or corresponding methyl- or or ethyl-substituted cycloalkyl groups or mono- or polyunsaturated cycloalkyl groups, such as cyclopentenyl or cyclopentadienyl, or branched or unbranched alkenyl having 2 to 10 C atoms, such as allyl, vinyl, isopropenyl, propenyl, or branched or unbranched alkynyl having 2 to 10 C atoms, such as ethynyl, propynyl, or
  • is an aryl radical having 6 to 20 C atoms which is either unsubstituted or mono- or polysubstituted, such as phenyl, napthyl, anthryl, phenanthryl, mono- or polysubstituted by substituents selected from the group consisting of NO[0062] 2, F, Cl, Br, NH2, NHA, NA2, OH and OA, where A can have the meanings given above, can be mono-, poly- or fully halogenated, preferably fluorinated, or
  • is an aralkyl radical having 7 to 20 C atoms, such as benzyl, optionally mono- or polysubstituted by substituents selected from the group consisting of NO[0063] 2, F, Cl, Br, NH2, NHA, NA2, OH and OA, where A can have the meanings given above, can be mono-, poly- or fully halogenated, preferably fluorinated,
  • is an aralkenyl or aralkynyl radical, where the aryl, alkenyl and alkynyl group can in each case have the given meanings, such as, for example, in phenylethynyl. [0064]
  • Furthermore, the radicals R[0065] 4 in the general formula (IIIa) or (IIIb) can be —Si(R6)3, —Sn(R6)3, —SR7, —OR7, —NR8R9, in which R6, R7, R8 and R9 independently of one another can have the abovementioned meanings or R8 and R9 are attached to one another and together form a cyclic ring having 3 to 8 C atoms which may optionally, in addition to a nitrogen atom, contain at least one heteroatom selected from the group consisting of —S—, —O— and —NR6—; or
  • two radicals R[0066] 4 in the general formula (IIIb) can be an alkyl having 2-7 C atoms, so that, in the reaction according to the invention, a compound of the general formula (I) is formed in which two radicals R4 form a cyclic ring having 3 to 8 atoms.
  • Particularly preferably, R[0067] 4 has the meaning of an alkyl radical, such as, for example, methyl, ethyl, n- or isopropyl, n-, sec- or t-butyl, pentyl, hexyl, or of a cycloalkyl radical, such as, for example, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, or of an aryl radical, such as, for example, phenyl, or of an aralkyl radical, such as, for example, benzyl.
  • The radical Z in the general formulae (IIIa) and (IIIb) preferably represents a radical MgX where X is Cl or Br, or the radical Z is lithium. [0068]
  • Particular preference according to the invention is given to using Grignard compounds such as: methylmagnesium bromide, ethylmagnesium bromide, n- or isopropylmagnesium bromide, iso-, sec- or tert-butylmagnesium bromide, n-hexylmagnesium bromide, cyclohexylmagnesium chloride, allylmagnesium bromide, vinylmagnesium bromide, cyclopentylmagnesium bromide, cyclopentylmagnesium chloride, phenylmagnesium bromide, benzylmagnesium chloride, for the reaction. [0069]
  • Furthermore, it was found that only if a cocatalyst is added, the geminal symmetric dialkylation reactions according to the invention start even at room temperature and result in the complete conversion of the starting materials in a relatively short reaction time. [0070]
  • Suitable cocatalysts for this reaction are metal isopropoxides and alkylsilyl halides. Particularly suitable are metal isopropoxides of the general formula (IV) and alkylsilyl halides of the general formula (V)[0071]
  • M′(s+)(O-isopropyl)s  (IV)
  • R3SiX  (V)
  • or of the general formula (VI)[0072]
  • R0—(X)m—Si—Y—(Si)p—(X)q—R0  (VII)
  • in which [0073]
  • M′ is Al, Ca, Na, K, Si or Mg, preferably Mg or Na, [0074]
  • s is an integer from 1 to 4 and is the oxidation state of the metal, [0075]
  • R is alkyl having 1 to 10 C atoms or aryl having 6 to 20 C atoms, [0076]
  • X is F, Cl, Br, CN, [0077]
  • m is 0, 1, [0078]
  • n is 1 to 10, [0079]
  • o is 0, 2, 3, [0080]
  • p is 0, 1 and [0081]
  • q is 0, 1, [0082]
  • with the proviso that o=3 and Y≠(CH[0083] 2)n if m=0.
  • Preference is given to using metal isopropoxides in which s is an integer from 1 to 4 and is the oxidation state of the metal and M′ is Al, Ca, Na, K, Si or Mg. Particular preference is given to Mg or Na. [0084]
  • Preference is given to using alkylsilyl halides in which R is alkyl having 1 to 6 C atoms. Particular preference is given to those in which R is alkyl having 1 to 3 C atoms and X is chlorine. [0085]
  • Particularly suitable cocatalysts are, inter alia, the following silicon compounds: [0086]
  • (CH[0087] 3)3SiCl
  • (CH[0088] 3)2ClSi(CH2)2SiCl(CH3)2
  • (CH[0089] 3)2ClSi(CH2)3CN
  • [(CH[0090] 3)3Si]2O
  • [(CH[0091] 3)3Si]2NH and
  • [(CH[0092] 3)3Si]2.
  • It has been found that the addition of from 0.7 to 1.2 mol, in particular from 0.9 and 1.1 mol, of a cocatalyst based on one mol of starting material leads to improved results such as, for example, higher yields, lower reaction temperature or shorter reaction times. [0093]
  • As can be demonstrated using examples, under favourable conditions a complete conversion of the carboxamide according to the general equation (Eq. 1) has taken place after just one hour: [0094]
    Figure US20030009029A1-20030109-C00015
  • For carrying out the process according to the invention, the catalyst used can be a commercial metal dioxide selected from the group consisting of titanium dioxide, zirconium dioxide and hafnium dioxide. Preference is given to using pulverulent titanium(IV) dioxide. In the simplest case, this can be of technical grade. To ensure simple removal after the reaction has ended, it is advantageous to choose a quality which is not too fine. The metal dioxide, preferably titanium dioxide, which is pre-dried by heating, is employed as a suspension in a suitable pre-dried solvent. Suitable solvents are, for example aliphatic or aromatic hydrocarbons or ethers. Preference is given to using solvents selected from the group consisting of toluene, THF, n-hexane, benzene and diethyl ether, which are dried prior to the reaction by methods known to the person skilled in the art. Drying can be carried out with the aid of magnesium sulphate, calcium chloride, sodium, potassium hydroxide or by other methods. [0095]
  • A preferred embodiment of the process according to the invention comprises initially charging the titanium dioxide used as catalyst in an amount of from 1 to 15, preferably 1.5 to 14, in particular 2 to 10 and very particularly preferably from 3 to 6 mol %, based on one mol of the amide used as starting material, in the form of a suspension adjusted to a temperature of from 10 to 30° C., preferably 15-25° C., particularly preferably to a temperature of about 20° C. Under an atmosphere of inert gas (nitrogen or argon), the starting material, either as such in liquid form or dissolved in a solvent selected from the group consisting of toluene, THF, n-hexane, benzene and diethyl ether, is slowly added dropwise with stirring. An amount of cocatalyst which corresponds to the amount to be reacted is then added dropwise, if required likewise in a solvent. The reaction mixture obtained is stirred for a short period, i.e. for a few minutes, at a constant temperature. Such an excess of the nucleophilic reagent of the general formula (IIIa) or (IIIb), in particular a Grignard reagent, is then slowly added to the resulting reaction mixture that substitution of the geminal carbonyl C atom by two identical substituents, i.e. a symmetric substitution of the geminal carbonyl C atom, can take place. The addition of a nucleophilic reagent according to the invention prepared by methods generally known to the person skilled in the art should take place at such a rate that the temperature of the reaction mixture does not exceed 50° C. It is advantageous to carry out the addition of the nucleophilic reagent, i.e. of the Grignard reagent or the lithium compound, with efficient mixing, preferably vigorous stirring. To shift the reaction equilibrium to the side of the desired symmetrically substituted product, the nucleophilic reagent used, preferably a Grignard reagent, is added in an amount of from 2.1 to 3 mol per mole of starting material that participates in the reaction. Preference is given to adding the Grignard reagent in an amount of from 2.2 to 2.6 mol, based on 1 mol of starting material. If a nucleophilic reagent or Grignard reagent of the general formula (IIIb) is used, only equimolar amounts, based on the starting material, are added to the reaction solution, corresponding to twice the number of reactive groups. [0096]
  • After the addition of the Grignard reagent has ended, the reaction mixture is stirred for some time at a constant temperature, until the reaction is brought to completion. [0097]
  • Another variant of the process according to the invention comprises preparing the Grignard reagent in situ by reacting magnesium with a compound of the general formula (IIIa′) or (IIIb′) in which R[0098] 4 and X have the meanings given above. In the in situ preparation of the Grignard compounds, the amount of magnesium is preferably 2 to 5 times the molar amount, preferably 2.8 to 3.2 times the molar amount, based on the compounds of the general formula (II) used as starting material, and the amount of the compound of the general formula (IIIa′) or (IIIb′) is 2 to 3.8 times the molar amount, preferably 2.2 to 2.6 times the molar amount, based on the compound of the general formula (II).
  • Thus, by the synthesis according to the invention it is possible to prepare symmetrically substituted amino compounds of the general formula (I) with good or satisfactory yields within adequate reaction times. In an advantageous manner, it is possible, by adding one of the catalysts in combination with one of the cocatalyst compounds described of the general formulae (IV), (V) or (VI), to reduce the reaction times considerably, in the most favourable case to one hour, without this resulting in a reduction in the yields obtained. [0099]
  • Thus, the present invention also provides the use of a catalyst system comprising a metal dioxide selected from the group consisting of titanium dioxide, zirconium dioxide and hafnium dioxide as catalyst and a compound of the general formulae (IV), (V) or (VI) with the meanings given above, and the use of this catalyst system for preparing the symmetrically substituted compounds of the general formula (I). [0100]
  • For example, 5 mmol of starting material are, at 20° C. and under an atmosphere of inert gas, added dropwise with stirring to a suspension of 3 mol % of titanium (IV) oxide in 40 ml of dried tetrahydrofuran. 5 mmol of cocatalyst, likewise taken up in dried tetrahydrofuran, are added slowly with stirring to this mixture. The mixture is stirred at 20° C. for 5 minutes, and 12 mmol of Grignard reagent are then added at such a rate that the temperature of the reaction mixture does not exceed 50° C. Stirring is continued for one hour, until the reaction has gone to completion. [0101]
  • After the reaction according to the invention, work-up of the reaction mixture can be carried out in a manner known to the person skilled in the art. [0102]
  • Here, the products can be precipitated as salts using solutions of hydrochloric acid, for example a 1 molar ethereal solution of hydrochloric acid, and be filtered off and, if required, purified by recrystallization. [0103]
  • To remove the Lewis acid, it is possible, for example, to add a suitable amount of saturated ammonium chloride solution and water, followed by further vigorous stirring for a plurality of hours (1-3 hours). The resulting precipitate is separated off and washed with a little ether, preferably diethyl ether. The filtrate is made alkaline (pH>10) by addition of a suitable base, such as an NaOH, KOH, sodium carbonate or potassium carbonate solution, preferably sodium hydroxide solution. The phases that are formed are then separated, and the aqueous phase is extracted repeatedly (for example in the special case given above three times with in each case 30 ml) with diethyl ether. The combined organic phases are washed with (for example 15 ml of) saturated sodium chloride solution and can be dried over potassium carbonate, magnesium sulphate or sodium sulphate and filtered. [0104]
  • The products can be purified by various routes using methods known to the person skilled in the art, such as, for example, in the following manner: [0105]
  • 1. They are precipitated as hydrochlorides using 1 M ethereal hydrochloric acid solution and filtered off (the resulting product is, if required, purified by recrystallization). [0106]
  • 2. The organic phase is extracted repeatedly with a 0.5 M acid solution, preferably an aqueous hydrochloric acid solution. The extract obtained is adjusted to pH>10 using bases, preferably 2 M aqueous sodium hydroxide solution, and extracted at least once, preferably repeatedly, with diethyl ether. The resulting organic phases, which contain the reaction product, can be dried, if appropriate, over potassium carbonate, magnesium sulphate or sodium sulphate and be freed from the organic solvent under reduced pressure. [0107]
  • 3. Furthermore, it is possible to isolate the reaction product by removing the organic solvent under reduced pressure and separating the residue that remains by column chromatography, to isolate the reaction product. [0108]
  • In the general description of the process procedure given above, the Grignard reagents can also be replaced by the corresponding lithium compounds. The corresponding lithium compounds, like the Grignard reagents, can be prepared by methods generally known to the person skilled in the art, and they can be reacted according to the invention in the same manner as described above. [0109]
  • The compounds of the general formula (I) prepared according to the invention can be used, for example, as intermediates in the preparation of sulphur- or selenium-containing amines for the chiral catalysis of diethyl zinc syntheses (literature: Werth, Thomas; Tetrahydron Lett. 36; 1995, 7849-7852, Werth, Thomas et al. Helv. Chim. Acta 79, 1996, 1957-1966). [0110]
  • To illustrate and better understand the present invention, examples are given below. However, owing to the general validity of the described principle of the invention, they are not meant to reduce the scope of the present application to just these examples.[0111]
  • EXAMPLES Titanium(IV)-oxide-induced Symmetric Dialkylation of Carboxamides Using Grignard Reagents
  • According to the reaction shown in Equation 1, the following reactions were carried out using one equivalent of (CH[0112] 3)3SiCl as cocatalyst:
    TABLE 2
    TiO2-induced reaction of carboxamide with R4MgX
    Figure US20030009029A1-20030109-C00016
    Figure US20030009029A1-20030109-C00017
    Figure US20030009029A1-20030109-C00018
    Reaction
    Amide Product Yield R4MgX conditions
    Figure US20030009029A1-20030109-C00019
    Figure US20030009029A1-20030109-C00020
    95%[6] PhMgBr 1 h/RT/ 3 mol % TiO2
    Figure US20030009029A1-20030109-C00021
    Figure US20030009029A1-20030109-C00022
    49%[6] Cyclopen tyl-MgCl 1 h/RT/ 13 mol % TiO2
    Figure US20030009029A1-20030109-C00023
    Figure US20030009029A1-20030109-C00024
    94%[6] n-Hexyl-MgBr 1 h/RT/ 13 mol % TiO2

Claims (14)

1. A process for preparing compounds of the general formula (I)
Figure US20030009029A1-20030109-C00025
in which
R1, R2 and R3 independently of one another are H, A, Ar, —Si(R6)3, —Sn(R6)3, —SR7, —OR7, —NR8R9 or R1 and R2 or R1 and R3 or R8 and R9 can be attached to one another and together form a cyclic ring having 3 to 8 C atoms which optionally contains, in addition to nitrogen, at least one further heteroatom selected from the group consisting of —S—, —O— and —NR6—,
R4 is A, Ar, —Si(R6)3, —Sn(R6)3, —SR7, —OR7, —NR8R9 in which R8 and R9 are as defined above or R8 and R9 or two radicals R4 can be attached to one another and together form a cyclic ring having 3 C atoms, R6, R7, R8 and R9 independently of one another are A or Ar,
A is a straight-chain or branched alkyl radical having from 1 to 10 C atoms, a straight-chain or branched alkenyl radical having 2 to 10 C atoms, or a straight-chain or branched alkynyl radical having 2-10 C atoms or a substituted or unsubstituted cycloalkyl radical having 3-8 C atoms, or a mono- or polyunsaturated cycloalkyl radical having 3-8 C atoms, and
Ar is a substituted or unsubstituted aryl radical having 6-20 C atoms, characterized in that a compound of the general formula (II)
Figure US20030009029A1-20030109-C00026
in which
R1, R2 and R3 have the meanings given above for the formula (I) is reacted with a reagent of the general formula (IIIa) or a nucleophilic reagent of the general formula (IIIb)
Z-R4  (IIIa)Z-R4—R4-Z  (IIIb)
in which
R4 has the meaning given for the formula (I), and
Z is Li or MgX where
X is Hal and
Hal is Cl, Br or I, which is/are generated in situ or added directly, and the process is carried out in the presence of catalytic amounts of a metal dioxide selected from the group consisting of titanium dioxide, zirconium dioxide and hafnium dioxide.
2. A process according to claim 1, characterized in that it is carried out in the presence of a cocatalyst.
3. A process according to claim 1, characterized in that it is carried out in the presence of a metal isopropoxide or an alkylsilyl halide cocatalyst.
4. A process according to claim 2, characterized in that the cocatalyst used is a metal isopropoxide of the general formula (IV) or an alkylsilyl halide of the general formula (V)
M′(s+) (O-isopropyl)s  (IV)R3SiX  (V)
in which
M′ is Al, Ca, Na, K, Si or Mg,
s is an integer from 1 to 4 and is the oxidation state of the metal,
R is alkyl having 1 to 10 C atoms or aryl having 6 to 20 C atoms,
X is F, Cl, Br, or CN.
5. A process according to claim 1, characterized in that the catalyst used is titanium dioxide.
6. A process according to claim 1, characterized in that
a) a carboxamide of the general formula (II), 1-15 mol %, based on the carboxamide, of a metal dioxide selected from the group consisting of titanium dioxide, zirconium dioxide and hafnium dioxide and, if appropriate, the cocatalyst are initially charged at 10-30° C. under an atmosphere of inert gas in a solvent selected from the group consisting of toluene, THF, n-hexane, benzene and diethyl ether,
b) a solution comprising a nucleophilic reagent of the general formula (IIIa) or (IIIb)
in which
R4 is A, Ar, —Si(R6)3, —Sn(R6)3, —SR7, —OR7, —NR8R9 in which R8 and R9 are as defined above or R8 and R9 or two radicals R4 can be attached to one another and together form a cyclic ring having 3 C atoms,
R6, R7, R8 and R9 independently of one another are A or Ar,
A is a straight-chain or branched alkyl radical having from 1 to 10 C atoms, a straight-chain or branched alkenyl radical having 2 to 10 C atoms, or a straight-chain or branched alkynyl radical having 2-10 C atoms or a substituted or unsubstituted cycloalkyl radical having 3-8 C atoms, or a mono- or polyunsaturated cycloalkyl radical having 3-8 C atoms, and
Ar is a substituted or unsubstituted aryl radical having 6-20 C atoms,
Z is Li or MgX where
X is Hal and
Hal is Cl, Br or I,
is added dropwise and
c) the mixture is allowed to react with stirring and, after the reaction has ended, worked up in a customary manner,
or in that, if Z=MgX,
a′) magnesium turnings, a carboxamide of the general formula (II), 1-15 mol %, based on the carboxamide, of a metal dioxide selected from the group consisting of titanium dioxide, zirconium dioxide and hafnium dioxide and, if appropriate, the cocatalyst are initially charged at 10-30° C. under an atmosphere of inert gas in a solvent selected from the group consisting of toluene, THF, n-hexane, benzene and diethyl ether,
b′) an alkyl halide, dissolved in a solvent selected from the group consisting of toluene, THF, n-hexane, benzene and diethyl ether, and of the general formula (IIIa′) of (IIIb′)
X—R4  (IIIa′)orX—R4—R4—X  (IIIb′)
in which
R4 is A, Ar, —Si(R6)3, —Sn(R6)3, —SR7, —OR7, —NR8R9 in which R8 and R9 are as defined above or R8 and R9 or two radicals R4 can be attached to one another and together form a cyclic ring having 3 C atoms,
R6, R7, R8 and R9 independently of one another are A or Ar,
A is a straight-chain or branched alkyl radical having from 1 to 10 C atoms, a straight-chain or branched alkenyl radical having 2 to 10 C atoms, or a straight-chain or branched alkynyl radical having 2-10 C atoms or a substituted or unsubstituted cycloalkyl radical having 3-8 C atoms, or a mono- or polyunsaturated cycloalkyl radical having 3-8 C atoms, and
Ar is a substituted or unsubstituted aryl radical having 6-20 C atoms,
X is Cl, Br, or I;
is added dropwise,
c′) the mixture is allowed to react with stirring and, after the reaction had ended, worked up in a customary manner.
7. A process according to claim 6, characterized in that the process step a) or a′) is carried out at a temperature of 15-25° C.
8. A process according to claim 6, characterized in that the process step a) or a′) is carried out at room temperature.
9. A process according to claim 1, characterized in that the nucleophilic reagent used is a lithium compound of the general formula (IIIa) or (IIIb) in which R4 is A, Ar, —Si(R6)3, —Sn(R6)3, —SR7, —OR7, —NR8R9 in which R8 and R9 are as defined above or R8 and R9 or two radicals R4 can be attached to one another and together form a cyclic ring having 3 C atoms,
R6, R7, R8 and R9 independently of one another are A or Ar,
A is a straight-chain or branched alkyl radical having from 1 to 10 C atoms, a straight-chain or branched alkenyl radical having 2 to 10 C atoms, or a straight-chain or branched alkynyl radical having 2-10 C atoms or a substituted or unsubstituted cycloalkyl radical having 3-8 C atoms, or a mono- or polyunsaturated cycloalkyl radical having 3-8 C atoms, and
Ar is a substituted or unsubstituted aryl radical having 6-20 C atoms.
10. A process according claim 1, characterized in that the compound that the nucleophilic reagent used is a compound of the general formula (IIIa) or (IIIb) in which R4 is methyl, ethyl, n- or isopropyl, iso-, sec- or tert-butyl, n-hexyl, cyclopentyl, cyclohexyl, allyl, vinyl, phenyl or benzyl.
11. A process according to claim 1, characterized in that the compound that is reacted is a compound of the general formula (II) in which R1, R2 and R3 independently of one another are H, methyl, ethyl, n- or isopropyl, iso-, sec- or tert-butyl, n-hexyl, phenyl or benzyl.
12. A process for preparing compounds of the general formula (I)
Figure US20030009029A1-20030109-C00027
in which
R1, R2 and R3 independently of one another are H, A, Ar, —Si(R6)3, —Sn(R6)3, —SR7, —OR7, —NR8R9 or R1 and R2 or R1 and R3 or R8 and R9 can be attached to one another and together form a cyclic ring having 3 to 8 C atoms which optionally contains, in addition to nitrogen, at least one further heteroatom selected from the group consisting of —S—, —O— and —NR6—,
R4 is A, Ar, —Si(R6)3, —Sn(R6)3, —SR7, —OR7, —NR8R9 in which R8 and R9 are as defined above or R8 and R9 or two radicals R4 can be attached to one another and together form a cyclic ring having 3 C atoms
R6, R7, R8 and R9 independently of one another are A or Ar,
A is a straight-chain or branched alkyl radical having from 1 to 10 C atoms, a straight-chain or branched alkenyl radical having 2 to 10 C atoms, or a straight-chain or branched alkynyl radical having 2-10 C atoms or a substituted or unsubstituted cycloalkyl radical having 3-8 C atoms, or a mono- or polyunsaturated cycloalkyl radical having 3-8 C atoms, by carrying out the process in the presence of a catalyst system, comprising a metal dioxide selected from the group consisting of titanium dioxide, and hafnium dioxide and a cocatalyst of the general formula (IV), (V)
M′(s+) (O-isopropyl)s  (IV)R3SiX  (V)
in which
M′ is Al, Ca, Na, K, Si or Mg,
s is an integer from 1 to 4 and is the oxidation state of the metal,
R is alkyl having 1 to 10 C atoms or aryl having 6 to 20 C atoms,
X is F, Cl, Br, or CN,
or the general formulae
(CH3)2ClSi(CH2)2SiCl(CH3)2
(CH3)2ClSi(CH2)3CN
[(CH3)3Si]2O
[(CH3)3Si]2NH or
[(CH3)3Si]2.
13. A process according to claim 4, wherein M1 is Mg or Na.
14. A process according to claim 12, wherein M1 is Mg or Na.
US10/162,257 1998-06-18 2002-06-05 Catalytic titanium (IV) oxide, mediated geminal symmetric dialkylation of carboxamides Abandoned US20030009029A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/162,257 US20030009029A1 (en) 1998-06-18 2002-06-05 Catalytic titanium (IV) oxide, mediated geminal symmetric dialkylation of carboxamides

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19827164.6 1998-06-18
DE19827164A DE19827164A1 (en) 1998-06-18 1998-06-18 Catalytic titanium (IV) oxide mediated geminal symmetrical dialkylation of carboxamides
US09/719,810 US6420302B1 (en) 1998-06-18 1999-06-18 Catalyst system
US10/162,257 US20030009029A1 (en) 1998-06-18 2002-06-05 Catalytic titanium (IV) oxide, mediated geminal symmetric dialkylation of carboxamides

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/719,810 Division US6420302B1 (en) 1998-06-18 1999-06-18 Catalyst system

Publications (1)

Publication Number Publication Date
US20030009029A1 true US20030009029A1 (en) 2003-01-09

Family

ID=7871278

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/719,810 Expired - Fee Related US6420302B1 (en) 1998-06-18 1999-06-18 Catalyst system
US10/162,257 Abandoned US20030009029A1 (en) 1998-06-18 2002-06-05 Catalytic titanium (IV) oxide, mediated geminal symmetric dialkylation of carboxamides

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/719,810 Expired - Fee Related US6420302B1 (en) 1998-06-18 1999-06-18 Catalyst system

Country Status (6)

Country Link
US (2) US6420302B1 (en)
EP (1) EP1087928A1 (en)
JP (1) JP2002518362A (en)
KR (1) KR20010052918A (en)
DE (1) DE19827164A1 (en)
WO (1) WO1999065859A1 (en)

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060111308A1 (en) * 2004-11-16 2006-05-25 Wendye Robbins Methods and compositions for therapeutic treatment
US20070087977A1 (en) * 2004-11-16 2007-04-19 Wendye Robbins Methods and compositions for treating pain
US20080138292A1 (en) * 2006-09-15 2008-06-12 Massachusetts Institute Of Technology Sensors for fluorescence and magnetic resonance imaging
US20080213377A1 (en) * 2006-12-08 2008-09-04 Bhatia Sangeeta N Delivery of Nanoparticles and/or Agents to Cells
WO2008105773A2 (en) 2006-03-31 2008-09-04 Massachusetts Institute Of Technology System for targeted delivery of therapeutic agents
US20080268063A1 (en) * 2004-11-04 2008-10-30 Sangyong Jon Coated Controlled Release Polymer Particles as Efficient Oral Delivery Vehicles for Biopharmaceuticals
US20090298710A1 (en) * 2005-12-15 2009-12-03 Farokhzad Omid C System for Screening Particles
US20090317802A1 (en) * 2005-12-09 2009-12-24 Bhatia Sangeeta N Compositions and Methods to Monitor RNA Delivery to Cells
US20100092425A1 (en) * 2008-10-12 2010-04-15 Von Andrian Ulrich Nicotine Immunonanotherapeutics
US20100129439A1 (en) * 2008-10-12 2010-05-27 Frank Alexis Adjuvant Incorporation in Immunonanotherapeutics
US20100144845A1 (en) * 2006-08-04 2010-06-10 Massachusetts Institute Of Technology Oligonucleotide systems for targeted intracellular delivery
US20100183727A1 (en) * 2008-10-12 2010-07-22 Matteo Iannacone Immunonanotherapeutics that Provide IgG Humoral Response Without T-Cell Antigen
US20100233251A1 (en) * 2007-10-12 2010-09-16 Massachusetts Institute of Technology Massachusetts Vaccine Nanotechnology
US20100297233A1 (en) * 2007-02-09 2010-11-25 Massachusetts Institute Of Technology Oscillating cell culture bioreactor
US20100303723A1 (en) * 2006-11-20 2010-12-02 Massachusetts Institute Of Technology Drug delivery systems using fc fragments
US20110020388A1 (en) * 2009-05-27 2011-01-27 Selecta Biosciences, Inc. Targeted synthetic nanocarriers with ph sensitive release of immunomodulatory agents
US20110052697A1 (en) * 2006-05-17 2011-03-03 Gwangju Institute Of Science & Technology Aptamer-Directed Drug Delivery
US8193334B2 (en) 2007-04-04 2012-06-05 The Brigham And Women's Hospital Polymer-encapsulated reverse micelles
US8323698B2 (en) 2006-05-15 2012-12-04 Massachusetts Institute Of Technology Polymers for functional particles
US8343497B2 (en) 2008-10-12 2013-01-01 The Brigham And Women's Hospital, Inc. Targeting of antigen presenting cells with immunonanotherapeutics
US9333179B2 (en) 2007-04-04 2016-05-10 Massachusetts Institute Of Technology Amphiphilic compound assisted nanoparticles for targeted delivery
US9381477B2 (en) 2006-06-23 2016-07-05 Massachusetts Institute Of Technology Microfluidic synthesis of organic nanoparticles
US9994443B2 (en) 2010-11-05 2018-06-12 Selecta Biosciences, Inc. Modified nicotinic compounds and related methods
US10039822B2 (en) 2011-04-29 2018-08-07 Selecta Biosciences, Inc. Method for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance immune responses

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19960377A1 (en) * 1999-12-14 2001-06-21 Merck Patent Gmbh Process for the preparation of combinatorial amine libraries

Cited By (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9492400B2 (en) 2004-11-04 2016-11-15 Massachusetts Institute Of Technology Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
US20080268063A1 (en) * 2004-11-04 2008-10-30 Sangyong Jon Coated Controlled Release Polymer Particles as Efficient Oral Delivery Vehicles for Biopharmaceuticals
US20090088394A1 (en) * 2004-11-16 2009-04-02 Wendye Robbins Methods and compositions for therapeutic treatment
US20070087977A1 (en) * 2004-11-16 2007-04-19 Wendye Robbins Methods and compositions for treating pain
US20060111308A1 (en) * 2004-11-16 2006-05-25 Wendye Robbins Methods and compositions for therapeutic treatment
US20090076053A1 (en) * 2004-11-16 2009-03-19 Wendye Robbins Methods and compositions for treating pain
US20090317802A1 (en) * 2005-12-09 2009-12-24 Bhatia Sangeeta N Compositions and Methods to Monitor RNA Delivery to Cells
US20090298710A1 (en) * 2005-12-15 2009-12-03 Farokhzad Omid C System for Screening Particles
US9267937B2 (en) 2005-12-15 2016-02-23 Massachusetts Institute Of Technology System for screening particles
WO2008105773A2 (en) 2006-03-31 2008-09-04 Massachusetts Institute Of Technology System for targeted delivery of therapeutic agents
US8802153B2 (en) 2006-03-31 2014-08-12 Massachusetts Institute Of Technology System for targeted delivery of therapeutic agents
US8709483B2 (en) 2006-03-31 2014-04-29 Massachusetts Institute Of Technology System for targeted delivery of therapeutic agents
US20100266491A1 (en) * 2006-03-31 2010-10-21 Massachusetts Institute Of Technology System for targeted delivery of therapeutic agents
US9080014B2 (en) 2006-05-15 2015-07-14 Massachusetts Institute Of Technology Polymers for functional particles
US9688812B2 (en) 2006-05-15 2017-06-27 Massachusetts Institute Of Technology Polymers for functional particles
US8367113B2 (en) 2006-05-15 2013-02-05 Massachusetts Institute Of Technology Polymers for functional particles
US8323698B2 (en) 2006-05-15 2012-12-04 Massachusetts Institute Of Technology Polymers for functional particles
US20110052697A1 (en) * 2006-05-17 2011-03-03 Gwangju Institute Of Science & Technology Aptamer-Directed Drug Delivery
US9381477B2 (en) 2006-06-23 2016-07-05 Massachusetts Institute Of Technology Microfluidic synthesis of organic nanoparticles
US20100144845A1 (en) * 2006-08-04 2010-06-10 Massachusetts Institute Of Technology Oligonucleotide systems for targeted intracellular delivery
US8133474B2 (en) 2006-09-15 2012-03-13 Massachusetts Institute Of Technology Sensors for fluorescence and magnetic resonance imaging
US20080138292A1 (en) * 2006-09-15 2008-06-12 Massachusetts Institute Of Technology Sensors for fluorescence and magnetic resonance imaging
US20100303723A1 (en) * 2006-11-20 2010-12-02 Massachusetts Institute Of Technology Drug delivery systems using fc fragments
US20080213377A1 (en) * 2006-12-08 2008-09-04 Bhatia Sangeeta N Delivery of Nanoparticles and/or Agents to Cells
US20100297233A1 (en) * 2007-02-09 2010-11-25 Massachusetts Institute Of Technology Oscillating cell culture bioreactor
US9217129B2 (en) 2007-02-09 2015-12-22 Massachusetts Institute Of Technology Oscillating cell culture bioreactor
US9333179B2 (en) 2007-04-04 2016-05-10 Massachusetts Institute Of Technology Amphiphilic compound assisted nanoparticles for targeted delivery
US8193334B2 (en) 2007-04-04 2012-06-05 The Brigham And Women's Hospital Polymer-encapsulated reverse micelles
US9474717B2 (en) 2007-10-12 2016-10-25 Massachusetts Institute Of Technology Vaccine nanotechnology
US9539210B2 (en) 2007-10-12 2017-01-10 Massachusetts Institute Of Technology Vaccine nanotechnology
US20100233251A1 (en) * 2007-10-12 2010-09-16 Massachusetts Institute of Technology Massachusetts Vaccine Nanotechnology
US10736848B2 (en) 2007-10-12 2020-08-11 Massachusetts Institute Of Technology Vaccine nanotechnology
US11547667B2 (en) 2007-10-12 2023-01-10 Massachusetts Institute Of Technology Vaccine nanotechnology
US9526702B2 (en) 2007-10-12 2016-12-27 Massachusetts Institute Of Technology Vaccine nanotechnology
US8343497B2 (en) 2008-10-12 2013-01-01 The Brigham And Women's Hospital, Inc. Targeting of antigen presenting cells with immunonanotherapeutics
US9439859B2 (en) 2008-10-12 2016-09-13 Massachusetts Institute Of Technology Adjuvant incorporation in immunoanotherapeutics
US8932595B2 (en) 2008-10-12 2015-01-13 Massachusetts Institute Of Technology Nicotine immunonanotherapeutics
US8906381B2 (en) 2008-10-12 2014-12-09 Massachusetts Institute Of Technology Immunonanotherapeutics that provide IGG humoral response without T-cell antigen
US9233072B2 (en) 2008-10-12 2016-01-12 Massachusetts Institute Of Technology Adjuvant incorporation in immunonanotherapeutics
US8637028B2 (en) 2008-10-12 2014-01-28 President And Fellows Of Harvard College Adjuvant incorporation in immunonanotherapeutics
US9308280B2 (en) 2008-10-12 2016-04-12 Massachusetts Institute Of Technology Targeting of antigen presenting cells with immunonanotherapeutics
US20100092425A1 (en) * 2008-10-12 2010-04-15 Von Andrian Ulrich Nicotine Immunonanotherapeutics
US8591905B2 (en) 2008-10-12 2013-11-26 The Brigham And Women's Hospital, Inc. Nicotine immunonanotherapeutics
US20100129439A1 (en) * 2008-10-12 2010-05-27 Frank Alexis Adjuvant Incorporation in Immunonanotherapeutics
US8562998B2 (en) 2008-10-12 2013-10-22 President And Fellows Of Harvard College Targeting of antigen presenting cells with immunonanotherapeutics
US8343498B2 (en) 2008-10-12 2013-01-01 Massachusetts Institute Of Technology Adjuvant incorporation in immunonanotherapeutics
US8277812B2 (en) 2008-10-12 2012-10-02 Massachusetts Institute Of Technology Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
US20100183727A1 (en) * 2008-10-12 2010-07-22 Matteo Iannacone Immunonanotherapeutics that Provide IgG Humoral Response Without T-Cell Antigen
US20110020388A1 (en) * 2009-05-27 2011-01-27 Selecta Biosciences, Inc. Targeted synthetic nanocarriers with ph sensitive release of immunomodulatory agents
US9884112B2 (en) 2009-05-27 2018-02-06 Selecta Biosciences, Inc. Immunomodulatory agent-polymeric compounds
US9006254B2 (en) 2009-05-27 2015-04-14 Selecta Biosciences, Inc. Immunomodulatory agent-polymeric compounds
US8629151B2 (en) 2009-05-27 2014-01-14 Selecta Biosciences, Inc. Immunomodulatory agent-polymeric compounds
US9994443B2 (en) 2010-11-05 2018-06-12 Selecta Biosciences, Inc. Modified nicotinic compounds and related methods
US10039822B2 (en) 2011-04-29 2018-08-07 Selecta Biosciences, Inc. Method for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance immune responses

Also Published As

Publication number Publication date
JP2002518362A (en) 2002-06-25
DE19827164A1 (en) 1999-12-23
KR20010052918A (en) 2001-06-25
EP1087928A1 (en) 2001-04-04
WO1999065859A1 (en) 1999-12-23
US6420302B1 (en) 2002-07-16

Similar Documents

Publication Publication Date Title
US6420302B1 (en) Catalyst system
US20040106818A1 (en) Process for the preparation of cyclohexanol derivatives
US6479661B1 (en) Method for symmetrically and asymmetrically disubstituting carboxylic acid amides with organotitanates and grignard reagents
WO2010053696A2 (en) Processes for the preparation of arylamine compounds
JP4565927B2 (en) Palladium catalyst for Heck reaction generating a carbon-carbon bond
US20030125549A1 (en) Process for the catalytic asymmetric disubstitution of carboxamides using 2 different Grignard reagents
US6448445B1 (en) Method for catalytically disubstituting carboxylic acid amides with at least one grignard reagent
US6515180B1 (en) Method for the catalytic, symmetric disubstitution of carboxylic acid amides with grignard reagents
JP4131575B2 (en) Production method of benzophenone imine
JP2002518360A (en) Catalytic titanium (IV) oxide-induced geminal asymmetric dialkylation of carboxamide
EP0831081B1 (en) Production of aminophenols
JP4114262B2 (en) Ferrocenylaminophosphine and catalyst containing the phosphine
KR20010053016A (en) Method for symmetrically and asymmetrically disubstituting carboxylic acid amides with organotitanates and grignard reagents
CN110730767B (en) Process for producing cycloalkyl (trifluoromethyl) benzene
TW448139B (en) Method of preparing benzyl metal compounds and method of preparing 4-phenyl-1-butenes using the same
JPH0355472B2 (en)
JPH1087610A (en) Production of n-substituted lactam
JP2006524247A5 (en)
EP3994144A1 (en) A new process for synthesizing c2 bridged cyclopentadienyl ligands and corresponding ansa-metallocene catalysts
CN114805436A (en) Organic phosphine oxide compound and synthesis method thereof
JPS63162674A (en) Production of 1-dodecylazacycloheptan-2-one
JPH10182681A (en) Production of bisalkylcyclopentadienyl complex compound
JPS59134743A (en) Preparation of m-phenoxytoluene
JPH07101964A (en) Production of silyl ether compounds
KR20010052929A (en) Method for producing combinatory amine libraries

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION